Drug Database
Back to search

Netherlands· NL-567de6728fe8

Nintedanib Accord 150 mg zachte capsules

A nintedanib product containing nintedanibesilaat, registered in Netherlands by Accord Healthcare S.L.U.. The same ATC class is registered in 14 of our 19 countries.

ATC L01EX09

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedNintedanib Accord 150 mg zachte capsu…ATCL01EX09REGISTER NO.NL-567de6728fe8PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nintedanibesilaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nintedanib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EX09 (nintedanib), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search nintedanib products by name

Nintedanib · ATC L01EX09

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nintedanib costs, country by country.

Normalised to the WHO defined daily dose (0.38 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Nintedanib · price per daily dose (0.38 g)

USD · FX 28 Sept 2026

  • US United States$51.13 (acquisition cost)
  • CH Switzerland$34.12
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
NINTEDANIBESILAAT
Manufacturer
Accord Healthcare S.L.U.
Country
Netherlands (NL)
ATC code
L01EX09
ATC class
Nintedanib
Defined daily dose
0.38 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/24/1803

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

160 interactions on record for nintedanib.

Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nintedanib against other medicinesHow interaction checks work

Nintedanib · interactions on record

160 records

  • 21 severe
  • 139 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • DexamethasoneH02AB02severe
  • RifampicinJ04AB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nintedanib in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nintedanib products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Nintedanib Cipla, Nintedanib Ratiopharm
  • Belgium · Nintedanib Accordpharma, Nintedanib Eg
  • Cyprus · Nintedanib Teva
  • Czechia · Nintedanib Glenmark, Nintedanib Sandoz
  • Germany · Nintedanib, Nintedanib 1 A Pharma
  • Denmark · Nintedanib "sandoz", Nintedanib Glenmark
  • Estonia · Agarf, Nintedanib Sandoz
  • Spain · Nintedanib, Nintedanib Accordpharma
  • Finland · Nintedanib Glenmark, Nintedanib Ratiopharm
  • France · Nintedanib Arrow, Nintedanib Biogaran
  • United Kingdom (Northern Ireland) · Nintedanib, Nintedanib Accord Healthcare
  • Greece · Nifib, Nindraf
  • Croatia · Gevesla, Nintedanib Accordpharma
  • Hungary · Nintedanib Accordpharma, Nintedanib Onkogen
  • Ireland · Nintedanib Accordpharma, Nintedanib Clonmel
  • Iceland · Agarf, Nintedanib Accord
  • Italy · Nintedanib Accordpharma, Nintedanib Aurobindo
  • Liechtenstein · Nintedanib Accord, Nintedanib Viatris
  • Lithuania · Agarf, Nintedanib Sandoz
  • Luxembourg · Nintedanib Eg, Nintedanib Eurogenerics
  • Latvia · Agarf, Nintedanib Sandoz
  • Malta · Nifiden Adalvo, Nintedanib Adalvo
  • Norway · Nintedanib Accord, Nintedanib Devatis
  • Poland · Nintedanib, Nintedanib Accordpharma
  • Portugal · Nintedanib Accordpharma, Nintedanib Eugia
  • Romania · Gevesla, Nintedanib Dr. Reddy’s
  • Sweden · Nintedanib Devatis, Nintedanib Glenmark
  • Slovenia · Nintedanib Accordpharma, Nintedanib Stada
  • Slovakia · Nintedanib Stada, Nintedanib Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed61703b-889a-4658-80c3-042fe998cbaf
GET /v1/drugs/ed61703b-889a-4658-80c3-042fe998cbaf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, zacht",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/nintedanib-accord-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Nintedanib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp130855",
  "excipients": [
    "AMMONIA (E 527)",
    "GELATINE (E 441)",
    "GLYCEROL (E 422)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "LAUROYLMACROGOLGLYCERIDEN",
    "LECITHINE (E 322)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "TITAANDIOXIDE (E 171)",
    "TRIGLYCERIDEN MIDDELLANGE KETEN",
    "WATER, GEZUIVERD",
    "ZWARTE INKT"
  ],
  "substances": [
    "NINTEDANIBESILAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2024/04/19",
  "procedure_number": "EMEA/H/C/006179",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/24/1803",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about nintedanib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console